These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8383016)

  • 1. Effect of selective angiotensin II receptor antagonism and angiotensin converting enzyme inhibition on the coronary vasculature in vivo. Intravascular two-dimensional and Doppler ultrasound studies.
    Sudhir K; MacGregor JS; Gupta M; Barbant SD; Redberg R; Yock PG; Chatterjee K
    Circulation; 1993 Mar; 87(3):931-8. PubMed ID: 8383016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary vasodilation induced by angiotensin-converting enzyme inhibition in vivo: differential contribution of nitric oxide and bradykinin in conductance and resistance arteries.
    Sudhir K; Chou TM; Hutchison SJ; Chatterjee K
    Circulation; 1996 May; 93(9):1734-9. PubMed ID: 8653880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibitors improve coronary flow reserve in dilated cardiomyopathy by a bradykinin-mediated, nitric oxide-dependent mechanism.
    Nikolaidis LA; Doverspike A; Huerbin R; Hentosz T; Shannon RP
    Circulation; 2002 Jun; 105(23):2785-90. PubMed ID: 12057995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers synergistically increase coronary blood flow in canine ischemic myocardium: role of bradykinin.
    Kitakaze M; Asanuma H; Funaya H; Node K; Takashima S; Sanada S; Asakura M; Ogita H; Kim J; Hori M
    J Am Coll Cardiol; 2002 Jul; 40(1):162-6. PubMed ID: 12103271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelium dependent vasomotor responses to endogenous agonists are potentiated following ACE inhibition by a bradykinin dependent mechanism.
    Zanzinger J; Zheng X; Bassenge E
    Cardiovasc Res; 1994 Feb; 28(2):209-14. PubMed ID: 8143302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential contribution of nitric oxide to regulation of vascular tone in coronary conductance and resistance arteries: intravascular ultrasound studies.
    Sudhir K; MacGregor JS; Amidon TM; Gupta M; Yock PG; Chatterjee K
    Am Heart J; 1994 Apr; 127(4 Pt 1):858-65. PubMed ID: 7512309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of coronary conductance and resistance vessel reactivity in response to nitroglycerin, ergonovine and adenosine: in vivo studies with simultaneous intravascular two-dimensional and Doppler ultrasound.
    Sudhir K; MacGregor JS; Barbant SD; Foster E; Fitzgerald PJ; Chatterjee K; Yock PG
    J Am Coll Cardiol; 1993 Apr; 21(5):1261-8. PubMed ID: 8459086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation.
    Farhy RD; Carretero OA; Ho KL; Scicli AG
    Circ Res; 1993 Jun; 72(6):1202-10. PubMed ID: 7684331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis.
    Takemoto M; Egashira K; Tomita H; Usui M; Okamoto H; Kitabatake A; Shimokawa H; Sueishi K; Takeshita A
    Hypertension; 1997 Dec; 30(6):1621-7. PubMed ID: 9403592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide mediates flow-dependent epicardial coronary vasodilation to changes in pulse frequency but not mean flow in conscious dogs.
    Canty JM; Schwartz JS
    Circulation; 1994 Jan; 89(1):375-84. PubMed ID: 8281673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glibenclamide, a specific inhibitor of ATP-sensitive K+ channels, inhibits coronary vasodilation induced by angiotensin II-receptor antagonists.
    Tada H; Egashira K; Yamamoto M; Ueno H; Takemoto M; Shimokawa H; Takeshita A
    J Cardiovasc Pharmacol; 1997 Sep; 30(3):313-9. PubMed ID: 9300314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic and coronary effects of the angiotensin II receptor antagonist EXP3174 in dogs.
    Richard V; Berdeaux A; Giudicelli JF
    J Cardiovasc Pharmacol; 1993 Jul; 22(1):52-7. PubMed ID: 7690096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between angiotensin receptor antagonism and converting enzyme inhibition in heart failure. Differential acute effects according to the renin-angiotensin system activation.
    Su J; Barbe F; Houël R; Guyene TT; Crozatier B; Hittinger L
    Basic Res Cardiol; 1999 Apr; 94(2):128-35. PubMed ID: 10326661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic treatment with losartan and enalaprilat on [3H]-norepinephrine release from isolated atria of Wistar-Kyoto and spontaneously hypertensive rats.
    Foucart S; Patrick SK; Oster L; de Champlain J
    Am J Hypertens; 1996 Jan; 9(1):61-9. PubMed ID: 8834708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation of coronary blood flow by ACE inhibition: role of angiotensin and bradykinin.
    Ruocco NA; Bergelson BA; Yu TK; Gavras I; Gavras H
    Clin Exp Hypertens; 1995 Oct; 17(7):1059-72. PubMed ID: 8556004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine impairs release of endothelium-derived relaxing factors in epicardial and resistance coronary arteries.
    Sudhir K; MacGregor JS; DeMarco T; De Groot CJ; Taylor RN; Chou TM; Yock PG; Chatterjee K
    Circulation; 1994 Dec; 90(6):3018-23. PubMed ID: 7994850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of angiotensin-converting enzyme inhibition with angiotensin II receptor antagonism in the human forearm.
    Cockcroft JR; Sciberras DG; Goldberg MR; Ritter JM
    J Cardiovasc Pharmacol; 1993 Oct; 22(4):579-84. PubMed ID: 7505360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of intimal thickening on coronary blood flow responses in orthotopic heart transplant recipients. A combined intravascular Doppler and ultrasound imaging study.
    Caracciolo EA; Wolford TL; Underwood RD; Donohue TJ; Bach RG; Miller LW; Kern MJ
    Circulation; 1995 Nov; 92(9 Suppl):II182-90. PubMed ID: 7586405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo.
    Chou TM; Sudhir K; Hutchison SJ; Ko E; Amidon TM; Collins P; Chatterjee K
    Circulation; 1996 Nov; 94(10):2614-9. PubMed ID: 8921808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.